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As an introduction to our experimental findings, it appears to us advantageous 
to give a brief review of the general theory of allergy, particularly as it relates 
to attempts to demonstrate passive transfer antibodies in allergic eczematous 
contact-type dermatitis. Our own passive transfer experiments in this cutaneous 
form of allergy have yielded only negative findings, and most of the transfer 
experiments from which other investigators have claimed positive results are in 
our opinion susceptible of different interpretations. 
We here follow closely the concepts of allergy as developed by Von Pirquet (1) 
and his school and as formulated by Sulzberger (2). Allergy is thus defined by 
a simple, most inclusive and least qualified statement as: any specifically acquired 
alteration in the capacity of living tissue to react to a substance. The words "altera-
tion" and "specifically" denote: 1) that the new capacity to react is ordinarily 
relatively lasting and is always characteristically different from the original 
capacity to react; 2) that the new capacity to react may be clinically greater 
or less than the original capacity to react; 3) that the new capacity to react is 
in some essential way dependent upon an original or previous exposure to the 
same or an immunologically related substance; and 4) that the new capacity 
to react becomes manifest upon reexposure only to the same or an immunolog-
ically related agent. The causal substance is generically designated an aller-
gen, i.e., an agent that is capable both of inducing an allergic state and of elicit-
ing the manifestations of that allergic state. When the allergen can be shown 
to evoke the elaboration of identifiable antibodies, then such an allergen is 
termed an antigen. 
The demonstration of antibodies is important in proving the existence of an 
alle~gic state or the allergic nature of a disease process. But such demonstra-
tion is certainly not absolutely essential to such proof. However, to explain 
the mechanism of induction, and maintenance, of an allergic state, the concept 
of antibody formation and antibody persistence is logical and helpful; the 
demonstration of the presence of specific antibodies and antigen-antibody inter-
action therefore often carries decisive weight in concluding that a process is 
based on allergy. This is not to say that failure to demonstrate antibodies by 
technics known at present in itself denies the allergic nature of a process. In-
deed, in many indisputable allergic states, antibodies are unknown and there is 
question if such antibodies will be found. Nevertheless, it is a common and 
1 From the New York Skin and Cancer Unit, Department of Dermatology and Syphil-
ology, New York Post Graduate Medical School and Hospital, Dr. Marion B. Sulzberger, 
Director. 
Received for publication January 10, 1948. 
425 
426 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
justified impression that one ought to be able to explain the phenomena of allergy 
in one way or another on the basis of interaction of allergens (antigens) with 
some constituent of tissues, body fluids or cells (i.e., with antibodies). As 
Doerr has written recently (3): "It seems to me permissible, when the demon-
stration of an antibody is not possible, or not constantly possible, to take refuge 
in the consideration that the phenomena observed in both man and animals 
cannot be explained in any other way than by the supposition of a pathogenic 
antigen-antibody reaction." We would like to criticize only the word "patho-
genic" in this statement for reasons which will appear below. The same reliance 
on antigen-antibody interaction as the explanation for allergic phenomena is to 
be found among other students of allergy, particularly the experimentalists. 
Our criticism of the word "pathogenic" in Doerr's statement rests on the specific re-
actions of antigen-antibody which result in abatement of clinical disease in vivo-for instance 
in diphtheria, or tetanus after the administration of antitoxin. These are clearly allergic 
processes in allergic states that are favorable to the allergic host. Here the clinical and 
laboratory manifestations of allergy are in the direction of hyposensitivity and specific, 
absolute, clinical anergy. In such circumstances, the state is one of immunity as an aller-
gically derived condition. Many allergists loosely conceive of allergy as synonymous with 
hypersensitivity alone; and confine the concept to allergic processes that result in clinical 
provocation of disease like anaphylactic states, serum sickness, hay fever, urticaria, etc. 
A13 Sulzberger has emphasized, there is no point, but only more confusion, in thus limiting 
the term allergy or the field of study of allergy to such pathologic states, when certain bene-
ficial and prophylactic processes, therapeutic modes and immune states are predicated on 
exactly similar or parallel immunologic mechanisms. Allergy, as Von Pirquet conceived 
and used the word, and as employed by many students in America (2, 4), is all inclusive of 
the phenomena of specific altered reactivity irrespective of the direction of the alteration or 
teleology with reference to the welfare of the organism involved. It spreads from extremes 
of specifically acquired immunity which may be completely protective, to specifically ac-
quired hypersensitivity which may be fatal. Moreover, it is quite possible too that some 
hypersensitivities are protective, or a stage toward immunity and therefore hardly "patho-
genic". 
We now direct our attention to the types of antibodies that are passively 
transferable, i.e., which confer upon the previously normal recipient tissue the 
specific acquired alteration of the donor of the antibodies. We find that these 
antibodies may be separated into two principal categories with opposite clinical 
characteristics: 
1. Sensitizing ant£bodies. These are substances that seem to be responsible 
for certain clinical disease processes of an allergic nature by reacting with corres-
ponding antigens which, in themselves and generally, seem to have no toxic or 
harmful qualities. Allergic states characterized by sensitizing antibodies mani-
fest themselves clinically by diseases or reactions of hypersensitivity. 
2. Neutralizing ant~oodies. These are substances that seem to prevent or 
cure certain disease processes by reacting with corresponding antigens which 
generally have inherently toxic or allergenic hannful effects. Allergic states 
characterized by neutralizing antibodies manifest themselves by specific clinical 
hyposensitivity, by specific anergy or by immunity. 
In many diseases, particularly the infectious granulomas, both types of anti-
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bodies seem to be simultaneously present, or the same antibody seems to have both 
sensitizing and neutralizing properties. This coincides with clinical observations 
where it is difficult to determine whether an effect is protective, or purely harm-
ful, or both. The more or less hypothetical antibodies that react with tuberculin, 
trichophytin, lepromin, Frei material and similar "antigens" seem to behave in 
such an ambivalent manner when compared to the clear-cut neutralizing or 
sensitizing properties of antibodies like antitoxins, bacterial agglutinins, atopic 
reagins, anaphylactic agglutinins and precipitins, etc. 
Since no naturally occurring antibody has been completely identified chem-
ically, although approximate or general chemical characteristics are well founded 
(5), the demonstration of antibodies rests on other technics which yield strong 
circumstantial evidence, such as the Prausnitz-Kuestner experiment, complement 
fixation, agglutination and precipitation reactions, bacteriolysis, the opsonic 
index, and similar routines. The quality of being passively transferable is a 
most convincing item in antibody identity. Table I is a compilation of data 
about some generally accepted transferable antibodies. 
In a small percentage of cutaneous allergies in human beings, passive transfer 
antibodies can be demonstrated and thus help to explain the allergic phenomena 
(e.g., a few cases of atopic dermatoses, some cases of urticaria, some exceptional 
drug eruptions etc.). However, in most forms of cutaneous allergies in human 
beings, no antibodies of any sort have been found regularly (i.e., in most cases 
of allergy to eczematogenic agents, to infectious agents, to drugs, etc.). In 
these types of allergic sensitization then, there is continued interest in the pos-
sibility of demonstrating antibodies by means of various technics, particularly 
by a technic of passive transfer. In the case of allergic eczematous contact-type 
dermatitis, the questions whether there are antibodies as classically conceived 
and where they are formed, located or operative are as yet unanswered. For 
some of the better known and better studied antibodies, like antitoxins and atopic 
reagins, facts like their presence in the blood stream, titratability, passive trans-
ferability, etc., are well substantiated. Their possible origin within the reticulo-
endothelial system, lymphocytes or plasma cells has been suggested on good 
evidence. Nothing of this sort exists for allergic eczematous contact-type 
dermatitis. The fact that an eczematogenic allergen (usually a simple chemical 
-not a protein) must interact with some substance which renders the skin 
capable of responding to it, strongly suggests that sensitizing antibodies are 
present somewhere. But, aside from the suggestion inherent in the highly 
specific reactions elicited by clinical exposure or by the patch tests with the 
eczematogenic allergen, there is no striking or indisputable evidence of antibodies . . 
Beginning with the schools of J. Jadassohn and Br. Bloch, search for the pres-
ence of antibodies in human allergic eczematous contact-type dermatitis has 
been assiduous, and a number of authors have claimed to have found such anti-
bodies. In sensitization experiments to simple chemicals using guinea pigs, 
Landsteiner and Chase (6) succeeded in passively transferring the sensitivity 
by means of a cellular peritoneal exudate injected into non-sensitized guinea 
pigs. However, although there are many resemblances between eczematous 
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sensitization to simple chemicals in human beings and skin sensitization to 
simple chemicals in guinea pigs, these forms of sensitization cannot yet be as-
sumed to be entirely identical. For exa:mple, from the written descriptions it 
TABLE I 
Antibodies demonstrable by skin tests after passi ve transfer 
EXAMPLES OF EXAMPLES OF FLUID THRU TYPE OF GENERAL NAME OF ANTIBODY CORRESPONDING ASSOCIATED WHICH ANTIBODY SKIN REACTION 
ANTIGEN ALLERGIC STATES IS TRANSFERRED ELICITED PROPERTIES 
Prausnitz-Kuest- So-called .. pro~ A topic dermatitis, Blood serum Immediate Thermolabile, 
ner antibody; tein" allergens allergic rhinitis, wheal sensitizing 
atopic reagin; (foods, inhalants, asthma, helmin- reaction 
passive transfer contactants); thiasis, some 
antibody; skin- certain parasites; cases of urticaria 
sensitizing anti- physical agents iocl . .. ,,,...,! 
body (e.g.light, cold); urticaria" 
rarely simple 
chemicals 
Neutralizing So-called "pro- Can be produced Blood serum Neutralization of I Thermostable, 
("blocking") an- tein" allergens deliberately thru antigen and neutralizing 
tibody (foods, inhalants, injection of ape- thus inhibition 
contactants) cific extracts. of immediate 
May occur span- wheal res<>tion 
taneously in produced by 
some cases of pol- interaction of 
linosis, Rh states, atopic reagin 
etc. and respective 
antigen 
Procutin Tuberculin and Sensitivity to tu- Fluid expresBed Increased re- Thermostable, 
perhaps products berculin and per- from papule of sponse (tu her- sensitizing 
or extracts of mi· haps products or tuberculin re- culin-type) to 
croorganisms extracts of mi- action ( & b load tuberculin skin 
other than Myco . croorganisms serum?) tests 
tuberculosis other than Myco. 
tuberculosis 
Anticutin Tuberculin and Lack of sensitivity Fluid expressed Decreased re- Thermolabile, 
perhaps products to tuberculin and from papule of sponse ( tu her- neutralizing 
or extracts of mi- perhaps products tuberculin re· culin-type) to 
croorganisms of extracts of mi- action (&blood tuberculin skin 
other thanMyco . croorganisms serum?) test 
tuberculosis other than Myco. 
tuberculosis 
Antitoxins Diptheria toxin, Diphth. immunity Blood serum Decreased re- Thermolabile 
Strep. Scarlet (Schick negativ- sponse to toxin neutralizing 
toxin ity) Scarlet fever 
Tetanus toxin, immunity (Dick 
etc. negativity) 
(Schulz-Char!-
ton phenome-
non) Tetanus 
immunity , etc. 
seems to us that cutaneous reactions in guinea pigs sensitized to simple chemicals 
have a certain amount of clinical urticarial component and that passive transfer 
possibilities could depend on this element rather than on the other clinical com-
ponents of these reactions. 
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In general, the technics employed up to now to demonstrate antibodies in 
allergic eczematous contact-type sensitization by passive transfer are relatively 
difficult, complicated, and altogether too full of sources of error. The reported 
positive results are therefore still debatable. The desideratum that is essential 
to proof for the passive transfer experiment of antibodies in allergic eczematous 
contact-type sensitization is the production of clinical and histologic eczematous 
changes in a normal recipient skin which has previously been prepared in some 
way with material from a sensitized donor's tissues, body fluids or cells and then 
exposed to the allergen which was the cause of the sensitization in the donor's 
skin. When the classical technic of the Prausnitz-Kuestner experiment is 
performed in an attempt to passively transfer allergic eczematous contact-type 
sensitivity, the results are usually completely negative. Exceptional instances 
(Biberstein (7)) in which such transfer has been reported have not been accepted 
as free of possible experimental or interpretative error (W. Jadassohn (8), Sulz-
berger (2)). 
A variation of the Prausnitz-Kuestner experiment involving the use of blister 
fluid obtained from the site of eczematous areas has been proposed and used 
by Koenigstein, Urbach and others. The procedure is as follows: 1. Raise a 
bulla with a non-specific primary vesicant agent on the skin of the sensitized 
donor in an area of affected skin or of healing or recently healed allergic eczema-
tous contact-type dermatitis. 2. Remove the blister fluid from the donor and 
inject it intracutaneously into a non-sensitive recipient's skin. 3. Finally, test 
the recipient's prepared site, after a reasonable "fixing" period of 24 to 48 hours, 
by means of the patch or drop test with the appropriate allergen. Successful 
passive transfer of allergic eczematous contact-type dermatitis has been claimed 
with this method by Urbach (9), Bizzozero and Ferrari (10), Mom and Bal-
lestero (11), and others. On the other hand, experienced investigators like W. 
Jadassohn (8), Sulzberger (2), and we ourselves have been unable to produce 
passive transfer of eczematous hypersensitivity by means of the Koenigstein-
Urbach technic. 
The most recent study on this subject in which positive results are claimed 
is that by Mom and Ballestero (11). These authors deliberately sensitized the 
skin of several subjects to dinitrochlorbenzene. They then deliberately produced 
areas of allergic eczematous contact-type dermatitis by dropping on dinitrochlor-
benzene. After involution of the acute clinical changes, they raised blisters over 
these areas by means of a cantharides paste, injected the blister fluids into the 
skins of normal recipients and 48 hours later tested the recipients' prepared areas 
by dropping on solutions of dinitrochlorbenzene. Positive clinical eczematous 
responseswere reported and illustrated. 
EXPERIMENTAL 
Our tests were carried out with the Koenigstein-Urbach technic in six subjects 
with typical allergic eczematous contact-type dermatitis. In each subject a patch 
test with the appropriate allergenic agent was first applied to the arm or upper 
back for 48 hours to produce clinical dermatitis. A significant degree of eczema-
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tous reaction was created in that time (see Table II). This reaction was per-
mitted to undergo involution over a period of five to seven days. After this 
interval of healing, the healed sites of the eczematous reaction were covered with 
a piece of cotton cloth moistened with tincture of cantharides (U.S.P.) under an 
Elastopatch.2 Twenty-four hours later the cantharides patch was removed. 
The approximately dime-sized blister which had been produced by the can-
tharides tincture was aspirated with a tuberculin syringe and 25 gauge hypodermic 
needle. One tenth cc. of the blister fluid was immediately injected intracutane-
TABLE II 
CONTltOL PATCH TESTS ON RECIPIENT 
PATCH TEST IlEAC-
TION ON RECIPIENT Patch test Patch test reac-
:RESULT 01!' IN SITE PREPARED reaction on Patch test tion on a site EXP. ALLEI<GEN TO WHICH PATCH TEST Wim SENSITIED another pre- reaction on a prepared with NO. DONOR WAS SENSITIVE DONOR'S BLISTER blister fluid ON DONO!< FLUID AND TESTED pared site but normal site from a normal} tested with a tested with WITHCORRE-
non-corre- corresponding donor and ' SPONDING ALLERGEN tested wi tb -spending allergen 
corresponding l allergen 
allergen 
--
1 Mere. bichloride, 3+ - - - -
1:1000 aq. solu-
tion 
2 Pyrethrum, as is 3+ - -
3 Nail polish, as is 2+ - - - -
4 Paraphenylenedi- 3+ - -
amine, 2% in 
petrolatum 
5 Nickel sulphate, 2+ - -
5% aq. sol. 
6 Salicylic acid, 4+ 1+* 1+* 
10% in petrola-
tum 
*Upon repetition of this patch test, the recipient in this case was again found to give 
positive reactions to this allergen on the normal skin as well as on the prepared site. In 
other words, this recipient was sensitive to salicylic acid prior to the experiment, and, it 
may be noted, the injection of blister fluid from a donor highly sensitive to the same sub-
stance did not enhance nor synergize the recipient's sensitivity. 
ously into the skin of the recipient subject. Twenty-four to 48 hours later the 
appropriate allergenic material was applied under a patch test to the site of the 
recipient's skin which had been prepared with the blister fluid. Forty-eight hours 
later this patch test was removed and the test readings made. Each recipient 
subject was used for tests with the blister fluid from only one donor subject. 
In each recipient subject a control patch test was done with the allergen atan 
unprepared site. In two subjects additional control tests were done as indicated 
in Table II. 
Table II shows the results of our tests and demonstrates that in all instances 
2 Made by Duke Laboratories, Stamford, Conn. 
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we were unable to transfer the eczematous hypersensitivity from sensitized donor 
to non-sensitive recipient subjects. 
DISCUSSION 
We failed completely in our attempts to transfer passively allergic eczematous 
hypersensitivity due to various eczematogenic allergens. Our technic corre-
sponded generally to that used originally by Koenigstein and Urbach and recently 
by Mom and Ballestero. However, in view of the different results obtained by 
Mom and Ballestero and by us, we call attention to the fact that the technic 
and procedure used in our tests varied from that used by Mom and Ballestero 
in the following respects: 
1. Our subjects were not deliberately sensitized to dinitrochlorbenzene but 
were selected at random from among our patients under treatment for allergic 
eczematous contact-type dermatitis of known cause. The allergen was a different 
one in each subject. 
2. We used tincture of cantharides (U.S.P.) and not cantharides paste for 
producing the bullae in our donor subjects. 
3. We injected 0.1 cc. of blister fluid in our recipient subjects and not 0.05 
or 0.5 cc. as reported in Mom and Ballestero's article. 
4. We did not centrifuge our blister fluid. Neither did Mom and Ballestero, 
according to the description of their technic. But in the legend to the photo in 
their article, they mention a centrifuged specimen. 
Some of the clinical events of allergic eczematous contact-type dermatitis 
suggest that the substance which enables or forces the skin to react with the 
allergen is formed in loco and remains cell fixed in situ. Some experimental 
procedures involving isolation of skin areas by surgical circumvallation tend to 
confirm this impression; others deny it (Rostenberg (12)). On the other hand, 
experiments in identical twins (Haxthausen (13)) involving transfer of sensitized 
skin by graft to non-sensitized subjects tend to throw considerable doubt on the 
concept of cell-fixed epidermal sensitizing antibodies or at least on the persistency 
of such fixed antibodies in cells. In any event, the reported results of experi-
ments designed to demonstrate antibodies in eczematous sensitizations are con-
tradictory; they cannot be regularly reproduced and are not dramatic like the 
Prausnitz-Kuestner experiment in many cases of the urticarial type of allergic 
sensitization. 
In some instances, an urticarial-type reaction, i.e., an immediate wheal re-
sponse, or a tuberculin-type, delayed reaction is produced in passive transfer 
experiments with blood serum from cases of allergic eczematous contact-type 
dermatitis, especially when the corresponding allergen is introduced intracu-
taneously. The interpretation of such responses in such cases is that the 
allergen had also caused urticarial or tuberculin type hypersensitivity in the 
donor and provoked the production of atopic reagins or other antibodies which 
revealed themselves in the recipient even if the donor did not present clinical 
evidence of urticarial or tuberculin-type hypersensitivity. The important point 
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here is that antibodies that may be said to be characteristic of allergic eczema-
tous contact-type sensitization and capable of passively inducing the clinical 
and histopathologic picture of eczematous dermatitis have not been conclusively 
and regularly demonstrated in the blood serum of subjects with allergic eczema-
tous contact-type dermatitis. 
SUMMARY AND CONCLUSIONS 
A review is presented of the general theory regarding passive transfer anti-
bodies in allergic dermatoses, with particular reference to antibodies in allergic 
eczematous contact-type dermatitis. It would appear on grounds of analogy 
that there must be substances within, or brought to the particular sensitized 
skin cells or tissue (epidermis?) which react with allergen to produce the clinical 
pictures of eczema and histopathologic pictures of spongiosis. Whatever evi-
dence there is for the existence of such specific substances (antibodies) is indirect 
and largely presumptive as yet. Some circumstantial evidence is claimed from 
experiments cited in the review, but in our cases of contact-type allergic eczema-
tous dermatitis, our attempts to confirm these claims have been unsuccessful. 
There is need, however, to pursue these studies to more conclusive issue. 
More experiments with modifications of technics suggested by the known 
phenomena of general antibody behavior are necessary. For instance, the 
transfer of plasma cells similar to the transfer experiments of Haxthausen (14) 
with lymphocytes from sensitive donors is suggested by the work of Fagraeus 
(15) . It may be that the physical and chemical characteristics of skin (epi-
dermal?) sensitizing antibodies do not permit their recovery in a complete, 
unaltered or reactive form by technics hitherto used. They may not be separable 
from their cutaneous milieu (epidermis?), may not persist, or may form and 
disappear early in the clinical episode. Whatever the true situation, the prob-
lem is unsolved and urgently in need of solution-both because of the basic and 
immunologic significance of a possible epithelial allergy and because of the fre-
quency and seriousness of disability from allergic eczematous contact-type 
dermatitis. 
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